Spectral Medical Inc T.EDT

COVID-19 and PMX treatment

[money4golf]

Interesting information from the ESTOR website.
Also interesting that Spectral mngt doesn't seem to like to discuss this.

COVID-19: the gut-lung axis – rationale for Polymyxin B hemoperfusion therapy
 
Toraymyxin^® has been used to treat severe unresponsive COVID-19 patients in  Europe, Russia, Asia and the U.S.
Toraymyxin^® has been approved by US FDA as Investigational Device Exemption (IDE) for the management of COVID-19 patients with septic shock and high level of endotoxemia (EAA™ = 0.6-0.9).                
Toraymyxin^® has been approved by Health Canada for the management of COVID-19 patients with severe ARF
https://www.estor.it/en/covid-19-the-gut-lung-axis-rationale-for-polymyxin-b-hemoperfusion-therapy/

[mercedesman]

Yes it's interesting Another thought on this.... Canada has lost roughtly 31,000 pepple to Covid-19, since the start of the pandemic.    Prior to Covid, the Cdn annual death rate due to Sepsis was about 30,000.* So has Covid-19 now in effect, doubled the number of Sepsis-like deaths? *This makes sense when comparing to CDA numbers for the US using 2017? stats...and Canada is a

[Domino55]

Maybe this discussion will become more pertinent and relevant once the option handout takes place. Who benefits again from ridiculously low share prices? it is nice to see that the 2% NPV has increased to 2.4% post tax loss.